Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Institute for Tuberculosis Research, University of Illinois at Chicago
Street 1: 833 S. Wood St. Rm 425, MC964
Street 2: MC 964
City: Chicago
Province: IL
Post Code: 60612-7231
Country: United States of America
Phone: 13123551715
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr
First Name: Scott
Last Name: Franzblau
Title: Professor and Director
Phone: 13123551715

Alternate Focal Point Contact Information

Salutation: Ms
First Name: Valsa
Last Name: Abraham
Title: Associate Director, Grants and Contracts

General Information

Board Constituency: Technical agencies
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Academic / Research Institution
Organization Type - Secondary: None
Organization Description:
Research directed towards new drug discovery and development for tuberculosis. Also develop rapid, inexpensive, low tech assays for drug susceptibility testing.
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Research and Development

Other Organization Information

Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 11 - 25
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
We are working to discovery new TB drugs that will shorten treatment duration.

Geographical Reach

Which country is your headquarters located in: United States of America
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Iran (Islamic Republic of)
Lao People's Democratic Republic
Russian Federation
South Africa
United Kingdom of Great Britain and Northern Ireland
United States of America
Viet Nam


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

New TB Drugs:
TB drug discovery including microbiology, natural products chemistry, medicinal chemistry, drug metabolism and pharmacokinetics.

Fundamental Research:
Evaluate new molecular targets and mechanisms of action of established and new candidate TB agents.


Declaration of interests:
No conflicts of interest were delacred.

Application date:  
Last updated: June 11, 2019